Wang, D. et al. Scientific traits of 138 hospitalized sufferers with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323, 1061–1069 (2020).
Huang, C. et al. Scientific options of sufferers contaminated with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020).
World Well being Group. Coronavirus Illness (COVID-19) Outbreak (World Well being Group, 2020).
Wu, F. et al. A brand new coronavirus related to human respiratory illness in China. Nature 579, 265–269 (2020).
Zhu, N. et al. A novel coronavirus from sufferers with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020).
Osterrieder, A. et al. Financial and social impacts of COVID-19 and public well being measures: Outcomes from an nameless on-line survey in Thailand, Malaysia, the UK, Italy and Slovenia. BMJ Open 11, e046863 (2021).
Clemente-Suárez, V. J. et al. The influence of the COVID-19 pandemic on social, well being, and financial system. Sustainability 13, 6314 (2021).
World Well being Group. COVID-19 Weekly Epidemiological Replace 1–23 (World Well being Group, 2021).
Fiolet, T., Kherabi, Y., MacDonald, C.-J., Ghosn, J. & Peiffer-Smadja, N. Evaluating COVID-19 vaccines for his or her traits, efficacy and effectiveness in opposition to SARS-CoV-2 and variants of concern: A story evaluate. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. https://doi.org/10.1016/j.cmi.2021.10.005 (2021).
Alencar, C. H. et al. Excessive effectiveness of SARS-CoV-2 vaccines in decreasing COVID-19-related deaths in over 75-year-olds, Ceará State, Brazil. Trop. Med. Infect. Dis. 6, 129 (2021).
Gupta, S. et al. Vaccinations in opposition to COVID-19 might have averted as much as 140,000 deaths in america. Well being Aff. (Millwood) 40, 1465–1472 (2021).
Buchan, S. A. et al. Effectiveness of COVID-19 vaccines in opposition to Omicron or Delta an infection. medRxiv. https://doi.org/10.1101/2021.12.30.21268565 (2022).
Eyre, D. W. et al. Impact of Covid-19 vaccination on transmission of alpha and delta variants. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2116597 (2022).
Lopez Bernal, J. et al. Effectiveness of Covid-19 vaccines in opposition to the B.1.617.2 (Delta) variant. N. Engl. J. Med. 385, 585–594 (2021).
Dawood, A. A. Mutated COVID-19 might foretell an amazing danger for mankind sooner or later. New Microbes New Infect. 35, 100673 (2020).
Korber, B. et al. Monitoring modifications in SARS-CoV-2 spike: Proof that D614G will increase infectivity of the COVID-19 virus. Cell 182, 812-827.e19 (2020).
Villoutreix, B. O., Calvez, V., Marcelin, A.-G. & Khatib, A.-M. In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus on the ACE2-Spike RBD Interface. Int. J. Mol. Sci. 22, 1695 (2021).
World Well being Group. Classification of Omicron 11–12 (World Well being Group, 2021).
Hodcroft, E. B. CoVariants: SARS-CoV-2 mutations and variants of curiosity (2021).
Hadfield, J. et al. Nextstrain: Actual-time monitoring of pathogen evolution. Bioinformatics 34, 4121–4123 (2018).
Wang, L. & Cheng, G. Sequence evaluation of the rising SARS-CoV-2 variant Omicron in South Africa. J. Med. Virol. 94, 1728–1733 (2021).
World Well being Group. Replace on Omicron 1–5 (World Well being Group, 2021).
Pulliam, J. R. C. et al. Elevated danger of SARS-CoV-2 reinfection related to emergence of the Omicron variant in South Africa. medRxiv. https://doi.org/10.1101/2021.11.11.21266068 (2021).
Lim, H. et al. Sizzling spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interplay obtained by density practical tight binding fragment molecular orbital methodology. Sci. Rep. 10, 16862 (2020).
Zhang, H. et al. The digestive system is a possible route of 2019-nCov an infection: A bioinformatics evaluation primarily based on single-cell transcriptomes. bioRxiv. https://doi.org/10.1101/2020.01.30.927806 (2020).
Wang, P. et al. Elevated resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell Host Microbe 29, 747–751 (2021).
Wei, C. et al. Proof for a mouse origin of the SARS-CoV-2 Omicron variant. J. Genet. Genomics https://doi.org/10.1016/j.jgg.2021.12.003 (2021).
Berger, I. & Schaffitzel, C. The SARS-CoV-2 spike protein: Balancing stability and infectivity. Cell Res. 30, 1059–1060 (2020).
Starr, T. N. et al. Deep mutational scanning of SARS-CoV-2 receptor binding area reveals constraints on folding and ACE2 binding. Cell 182, 1295-1310.e20 (2020).
Tian, F. et al. N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2. Elife 10, e69091 (2021).
Luan, B., Wang, H. & Huynh, T. Molecular mechanism of the N501Y mutation for enhanced binding between SARS-CoV-2’s spike protein and human ACE2 receptor. bioRxiv. https://doi.org/10.1101/2021.01.04.425316 (2021).
Meng, B. et al. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its function within the Alpha variant B.1.1.7. Cell Rep. 35, 109292 (2021).
Lan, J. et al. Construction of the SARS-CoV-2 spike receptor-binding area certain to the ACE2 receptor. Nature 581, 215–220 (2020).
Li, F., Li, W., Farzan, M. & Harrison, S. C. Construction of SARS coronavirus spike receptor-binding area complexed with receptor. Science 309, 1864–1868 (2005).
Huang, Y., Yang, C., Xu, X., Xu, W. & Liu, S. Structural and practical properties of SARS-CoV-2 spike protein: Potential antivirus drug improvement for COVID-19. Acta Pharmacol. Sin. 41, 1141–1149 (2020).
Xiao, X., Chakraborti, S., Dimitrov, A. S., Gramatikoff, Ok. & Dimitrov, D. S. The SARS-CoV S glycoprotein: Expression and practical characterization. Biochem. Biophys. Res. Commun. 312, 1159–1164 (2003).
Wong, S. Ok., Li, W., Moore, M. J., Choe, H. & Farzan, M. A 193-amino acid fragment of the SARS coronavirus S protein effectively binds angiotensin-converting enzyme 2. J. Biol. Chem. 279, 3197–3201 (2004).
Junxian, O. et al. V367F mutation in SARS-CoV-2 spike RBD rising through the early transmission part enhances viral infectivity by elevated human ACE2 receptor binding affinity. J. Virol. 95, e00617-21 (2021).
Daniel, W. et al. Cryo-EM construction of the 2019-nCoV spike within the prefusion conformation. Science 367, 1260–1263 (2020).
Bosch, B. J., van der Zee, R., de Haan, C. A. M. & Rottier, P. J. M. The coronavirus spike protein is a category I virus fusion protein: Structural and practical characterization of the fusion core complicated. J. Virol. 77, 8801–8811 (2003).
Hoffmann, M. et al. SARS-CoV-2 cell entry is determined by ACE2 and TMPRSS2 and is blocked by a clinically confirmed protease inhibitor. Cell 181, 271-280.e8 (2020).
Harvey, W. T. et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. 19, 409–424 (2021).
Donoghue, M. et al. A novel angiotensin-converting enzyme–associated carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ. Res. 87, e1–e9 (2000).
Zhao, Y. et al. Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. bioRxiv. https://doi.org/10.1101/2020.01.26.919985 (2020).
Guo, J., Huang, Z., Lin, L. & Lv, J. Coronavirus illness 2019 (COVID-19) and heart problems: A viewpoint on the potential affect of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of extreme acute respiratory syndrome coronavirus 2 an infection. J. Am. Coronary heart Assoc. 9, e016219 (2020).
Shang, J. et al. Structural foundation of receptor recognition by SARS-CoV-2. Nature 581, 221–224 (2020).
Yushun, W. et al. Receptor recognition by the novel coronavirus from Wuhan: An evaluation primarily based on decade-long structural research of SARS coronavirus. J. Virol. 94, e00127-20 (2021).
Bai, C. & Warshel, A. Vital variations between the binding options of the spike proteins of SARS-CoV-2 and SARS-CoV. J. Phys. Chem. B 124, 5907–5912 (2020).
Bai, C. et al. Predicting mutational results on receptor binding of the spike protein of SARS-CoV-2 variants. J. Am. Chem. Soc. 143, 17646–17654. https://doi.org/10.1021/jacs.1c07965 (2021).
Chen, J., Wang, R., Gilby, N. B. & Wei, G. Omicron variant (B.1.1.529): Infectivity, vaccine breakthrough, and antibody resistance. J. Chem. Inf. Mannequin. https://doi.org/10.1021/acs.jcim.1c01451 (2021).
Kumar, R., Murugan, N. A. & Srivastava, V. Improved binding affinity of omicron’s spike protein for the human angiotensin-converting enzyme 2 receptor is the important thing behind its elevated virulence. Int. J. Mol. Sci. 23, 3409 (2022).
Socher, E., Heger, L., Paulsen, F., Zunke, F. & Arnold, P. Molecular dynamics simulations of the delta and omicron SARS-CoV-2 spike–ACE2 complexes reveal distinct modifications between each variants. Comput. Struct. Biotechnol. J. 20, 1168–1176 (2022).
Miotto, M. et al. Inferring the stabilization results of SARS-CoV-2 variants on the binding with ACE2 receptor. Commun. Biol. 5, 20221 (2022).
Hamelberg, D., Mongan, J. & McCammon, J. A. Accelerated molecular dynamics: A promising and environment friendly simulation methodology for biomolecules. J. Chem. Phys. 120, 11919–11929 (2004).
Kukol, A. Molecular Modeling of Proteins, 2nd edn, 1215 (2014).
Watanabe, Y., Allen, J. D., Wrapp, D., McLellan, J. S. & Crispin, M. Web site-specific glycan evaluation of the SARS-CoV-2 spike. Science 369, 330–333 (2020).
Søndergaard, C. R., Olsson, M. H. M., Rostkowski, M. & Jensen, J. H. Improved therapy of ligands and coupling results in empirical calculation and rationalization of pKa values. J. Chem. Idea Comput. 7, 2284–2295 (2011).
Maier, J. A. et al. ff14SB: Enhancing the accuracy of protein aspect chain and spine parameters from ff99SB. J. Chem. Idea Comput. 11, 3696–3713 (2015).
Case, D. A., Betz, R. M., Cerutti, D. S., Cheatham, T. E. III, Darden, T. A., Duke, R. E., Giese, T. J., Gohlke, H., Goetz, A. W., Homeyer, N., Izadi, S., Janowski, P., Kaus, J., Kovalenko, A., Lee, T. S., LeGrand, S., Li, P., Lin, C., Luchko, T., Luo, R., Madej, B. & Mermelstein, D. L. X. and P. A. Ok. AMBER 2016 (Univ. California, 2016).
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparability of straightforward potential capabilities for simulating liquid water. J. Chem. Phys. 79, 926–935 (1983).
Kräutler, V., van Gunsteren, W. F. & Hünenberger, P. H. A quick SHAKE algorithm to unravel distance constraint equations for small molecules in molecular dynamics simulations. J. Comput. Chem. 22, 501–508 (2001).
Voter, A. F. A way for accelerating the molecular dynamics simulation of rare occasions. J. Chem. Phys. 106, 4665–4677 (1997).
Voter, A. F. Hyperdynamics: Accelerated molecular dynamics of rare occasions. Phys. Rev. Lett. 78, 3908–3911 (1997).
Hamelberg, D. & McCammon, J. A. Quick peptidyl cis–trans isomerization throughout the versatile Gly-rich flaps of HIV-1 protease. J. Am. Chem. Soc. 127, 13778–13779 (2005).
Markwick, P. R. L., Bouvignies, G. & Blackledge, M. Exploring a number of timescale motions in protein GB3 utilizing accelerated molecular dynamics and NMR spectroscopy. J. Am. Chem. Soc. 129, 4724–4730 (2007).
Bucher, D., Pierce, L. C. T., McCammon, J. A. & Markwick, P. R. L. On the usage of accelerated molecular dynamics to reinforce configurational sampling in ab initio simulations. J. Chem. Idea Comput. 7, 890–897 (2011).
Pierce, L. C. T. et al. Routine entry to millisecond time scale occasions with accelerated molecular dynamics. J. Chem. Idea Comput. 8, 2997–3002 (2012).
Berndt, Ok. D., Beunink, J., Schroeder, W. & Wuethrich, Ok. Designed substitute of an inner hydration water molecule in BPTI: Structural and practical implications of a Gly-to-Ser mutation. Biochemistry 32, 4564–4570 (1993).
Cheng, M. H., Kaya, C. & Bahar, I. Quantitative evaluation of the energetics of dopamine translocation by human dopamine transporter. J. Phys. Chem. B 122, 5336–5346 (2018).
Wang, J., Alekseenko, A., Kozakov, D. & Miao, Y. Improved modeling of peptide–protein binding by world docking and accelerated molecular dynamics simulations. Entrance. Mol. Biosci. 6, 112 (2019).
Patrick, R. et al. Utilizing accelerated molecular dynamics simulation to elucidate the consequences of the T198F mutation on the molecular flexibility of the West Nile virus envelope protein. Sci. Rep. 10, 9625. https://doi.org/10.1038/s41598-020-66344-8 (2020).
Markwick, P. R. L. & McCammon, J. A. Finding out practical dynamics in bio-molecules utilizing accelerated molecular dynamics. Phys. Chem. Chem. Phys. 13, 20053–20065 (2011).
Roe, D. R., Bergonzo, C. & Cheatham, T. E. Analysis of enhanced sampling supplied by accelerated molecular dynamics with Hamiltonian duplicate trade strategies. J. Phys. Chem. B 118, 3543–3552 (2014).
Li, C. et al. Conformational modifications of glutamine 5′-phosphoribosylpyrophosphate amidotransferase for 2 substrates analogue binding: Perception from typical molecular dynamics and accelerated molecular dynamics simulations. Entrance. Chem. 9, 51 (2021).
Grant, B. J., Rodrigues, A. P. C. C., ElSawy, Ok. M., McCammon, J. A. & Caves, L. S. D. D. Bio3d: An R package deal for the comparative evaluation of protein buildings. Bioinformatics 22, 2695–2696 (2006).
da Costa, C. H. S. et al. Evaluation of the PETase conformational modifications induced by poly(ethylene terephthalate) binding. Proteins Struct. Funct. Bioinform. (2021).
Costa, C. H. S. et al. Computational research of conformational modifications in human 3-hydroxy-3-methylglutaryl coenzyme reductase induced by substrate binding. J. Biomol. Struct. Dyn. 37, 4374–4383 (2019).
da Costa, C. H. S. et al. Unraveling the conformational dynamics of glycerol 3-phosphate dehydrogenase, a nicotinamide adenine dinucleotide-dependent enzyme of Leishmania mexicana. J. Biomol. Struct. Dyn. https://doi.org/10.1080/07391102.2020.1742206 (2020).
Grosso, M., Kalstein, A., Parisi, G., Roitberg, A. E. & Fernandez-Alberti, S. On the evaluation and comparability of conformer-specific important dynamics upon ligand binding to a protein. J. Chem. Phys. 142, 245101 (2015).
Srinivasan, J., Cheatham, T. E., Cieplak, P., Kollman, P. A. & Case, D. A. Continuum solvent research of the steadiness of DNA, RNA, and phosphoramidate–DNA helices. J. Am. Chem. Soc. 120, 9401–9409 (1998).
Kollman, P. A. et al. Calculating buildings and free energies of complicated molecules: Combining molecular mechanics and continuum fashions. Acc. Chem. Res. 33, 889–897 (2000).
Lill, M. A. & Thompson, J. J. Solvent interplay power calculations on molecular dynamics trajectories: Rising the effectivity utilizing systematic body choice. J. Chem. Inf. Mannequin. 51, 2680–2689 (2011).
Case, D. A. et al. The Amber biomolecular simulation packages. J. Comput. Chem. 26, 1668–1688 (2005).
Cui, Q. et al. Molecular dynamics—solvated interplay power research of protein-protein interactions: The MP1–p14 scaffolding complicated. J. Mol. Biol. 379, 787–802 (2008).
Yang, Y., Liu, H. & Yao, X. Understanding the molecular foundation of MK2-p38α signaling complicated meeting: Insights into protein-protein interplay by molecular dynamics and free power research. Mol. Biosyst. 8, 2106–2118 (2012).
Schubert, M. et al. Human serum from SARS-CoV-2-vaccinated and COVID-19 sufferers exhibits lowered binding to the RBD of SARS-CoV-2 Omicron variant. BMC Med. 20, 102 (2022).
Wu, L. et al. SARS-CoV-2 Omicron RBD exhibits weaker binding affinity than the at present dominant Delta variant to human ACE2. Sign Transduct. Goal. Ther. 7, 8 (2022).
Han, P. et al. Receptor binding and complicated buildings of human ACE2 to spike RBD from omicron and delta SARS-CoV-2. Cell 185, 630-640.e10 (2022).
Dhiraj, M. et al. SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM construction of spike protein–ACE2 complicated. Science 375, 760–764 (2022).
Lin, S. et al. Characterization of SARS-CoV-2 Omicron spike RBD reveals considerably decreased stability, extreme evasion of neutralizing-antibody recognition however unaffected engagement by decoy ACE2 modified for enhanced RBD binding. Sign Transduct. Goal. Ther. 7, 56 (2022).
Woo, H. G. & Shah, M. Omicron: A closely mutated SARS-CoV-2 variant displays stronger binding to ACE2 and potently escape permitted COVID-19 therapeutic antibodies. Entrance. Immunol. 12, 830527 (2021).